Allergic reaction upon intravitreal administration of anti–vascular endothelial growth factor agents
Conclusion:
Bevacizumab and ranibizumab are derivatives of murine monoclonal antibodies, whereas pegaptanib is an aptamer and aflibercept is a fusion protein of human origin. These chemical origins may allow patients to receive pegaptanib or aflibercept despite having allergy to bevacizumab or ranibizumab.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Case Report Source Type: research
More News: Allergy | Allergy & Immunology | Avastin | Chemistry | Lucentis | Opthalmology | Ranibizumab Injection | Vitamin A